Andrea Altieri

Summary

Affiliation: German Cancer Research Center
Country: Germany

Publications

  1. ncbi Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database
    Andrea Altieri
    Division of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany
    Blood 106:668-72. 2005
  2. ncbi Familial risks and temporal incidence trends of multiple myeloma
    Andrea Altieri
    Division of Molecular Genetic Epidemiology, German Cancer Research Centre, DKFZ, Im Neuenheimer Feld 580, D 69120 Heidelberg, Germany
    Eur J Cancer 42:1661-70. 2006
  3. doi Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression
    Asta Forsti
    Department of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany
    Genes Chromosomes Cancer 49:270-81. 2010
  4. ncbi PAI-1 -675 4G/5G polymorphism as a prognostic biomarker in breast cancer
    Haixin Lei
    Division of Molecular Genetic Epidemiology C050, German Cancer Research Center DKFZ, Im Neuenheimer Feld 580, 69120, Heidelberg, Germany
    Breast Cancer Res Treat 109:165-75. 2008
  5. doi Interleukin promoter polymorphisms and prognosis in colorectal cancer
    Stefan Wilkening
    Division of Molecular Genetic Epidemiology, German Cancer Research Center DKFZ, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany
    Carcinogenesis 29:1202-6. 2008
  6. ncbi Association between number of siblings and nervous system tumors suggests an infectious etiology
    Andrea Altieri
    Deutsches Krebsforschungszentrum DKFZ, Division of Molecular Genetic Epidemiology, Im Neuenheimer Feld 580, D 69120 Heidelberg, Germany
    Neurology 67:1979-83. 2006
  7. ncbi Number of siblings and the risk of lymphoma, leukemia, and myeloma by histopathology
    Andrea Altieri
    Division of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg
    Cancer Epidemiol Biomarkers Prev 15:1281-6. 2006
  8. ncbi Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression
    Haixin Lei
    Division of Molecular Genetic Epidemiology, German Cancer Research Center DKFZ, Im Neuenheimer Feld 580, D 69120 Heidelberg, Germany
    Breast Cancer Res Treat 103:61-9. 2007
  9. ncbi Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy)
    Luigi Naldi
    Clinica Dermatologica, Ospedali Riuniti di Bergamo, Universita degli Studi di Milano Bicocca, Bergamo, Italy
    Cancer Causes Control 16:893-9. 2005
  10. ncbi Single nucleotide polymorphisms in the DMBT1 promoter and the progression of breast cancer
    Haixin Lei
    Int J Cancer 120:447-9. 2007

Collaborators

Detail Information

Publications15

  1. ncbi Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database
    Andrea Altieri
    Division of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany
    Blood 106:668-72. 2005
    ..The patterns of risks in parents and siblings support the hypothesis of an autosomal-dominant component for diffuse large B-cell NHL and a recessive one for follicular NHL...
  2. ncbi Familial risks and temporal incidence trends of multiple myeloma
    Andrea Altieri
    Division of Molecular Genetic Epidemiology, German Cancer Research Centre, DKFZ, Im Neuenheimer Feld 580, D 69120 Heidelberg, Germany
    Eur J Cancer 42:1661-70. 2006
    ..If environmental factors can be excluded, the pattern of familial risk of MM is consistent with an autosomal dominant mode of inheritance...
  3. doi Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression
    Asta Forsti
    Department of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany
    Genes Chromosomes Cancer 49:270-81. 2010
    ..63, 95%CI: 1.08-2.46). As this is the first study about the influence of the polymorphisms in the TGFB1 pathway on CRC progression, further studies in large independent cohorts are warranted...
  4. ncbi PAI-1 -675 4G/5G polymorphism as a prognostic biomarker in breast cancer
    Haixin Lei
    Division of Molecular Genetic Epidemiology C050, German Cancer Research Center DKFZ, Im Neuenheimer Feld 580, 69120, Heidelberg, Germany
    Breast Cancer Res Treat 109:165-75. 2008
    ..5G/5G homozygotes were also the group with worse survival among lymph node negative cases. Our finding suggests that genotyping PAI-1 -675 4G/5G may help in clinical prognosis of breast cancer...
  5. doi Interleukin promoter polymorphisms and prognosis in colorectal cancer
    Stefan Wilkening
    Division of Molecular Genetic Epidemiology, German Cancer Research Center DKFZ, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany
    Carcinogenesis 29:1202-6. 2008
    ..The predicted biological effect of these SNPs in relation to promotion of cancer progression is consistent with the observed increased survival time...
  6. ncbi Association between number of siblings and nervous system tumors suggests an infectious etiology
    Andrea Altieri
    Deutsches Krebsforschungszentrum DKFZ, Division of Molecular Genetic Epidemiology, Im Neuenheimer Feld 580, D 69120 Heidelberg, Germany
    Neurology 67:1979-83. 2006
    ..To estimate the effect of the number of siblings on the risk of histopathologic subtypes of tumors of the nervous system using large population-based data...
  7. ncbi Number of siblings and the risk of lymphoma, leukemia, and myeloma by histopathology
    Andrea Altieri
    Division of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg
    Cancer Epidemiol Biomarkers Prev 15:1281-6. 2006
    ..The remarkable protective effect of number of older siblings on acute monocytic leukemia is a novel finding of potential interest. Possible interpretations of our findings in the context of a putative infectious etiology are discussed...
  8. ncbi Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression
    Haixin Lei
    Division of Molecular Genetic Epidemiology, German Cancer Research Center DKFZ, Im Neuenheimer Feld 580, D 69120 Heidelberg, Germany
    Breast Cancer Res Treat 103:61-9. 2007
    ..34, 95% CI 1.08-5.08). Although our study suggests some correlations between the studied SNPs and the progression of breast cancer, the rarity of the risk genotypes limits their usefulness in the clinic...
  9. ncbi Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy)
    Luigi Naldi
    Clinica Dermatologica, Ospedali Riuniti di Bergamo, Universita degli Studi di Milano Bicocca, Bergamo, Italy
    Cancer Causes Control 16:893-9. 2005
    ..The aim of the study was to examine the relation between sun exposure and other selected risk factors and the development of different clinico-pathological variants of cutaneous malignant melanoma (CMM) at different body locations...
  10. ncbi Single nucleotide polymorphisms in the DMBT1 promoter and the progression of breast cancer
    Haixin Lei
    Int J Cancer 120:447-9. 2007
  11. ncbi Number of siblings and risk of hodgkin's and other lymphoid neoplasms
    Liliane Chatenoud
    Cancer Epidemiol Biomarkers Prev 14:552. 2005
  12. ncbi Occupational and leisure time physical activity and the risk of nonfatal acute myocardial infarction in Italy
    Andrea Altieri
    Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
    Ann Epidemiol 14:461-6. 2004
    ..However, the quantitative estimates of the possible protective role of physical activity appear to vary across studies and populations...
  13. ncbi Influence of education level on breast cancer risk and survival in Sweden between 1990 and 2004
    Shehnaz K Hussain
    Center for Family and Community Medicine, Karolinska Institute, Huddinge, Sweden
    Int J Cancer 122:165-9. 2008
    ..68, 95% CI: 0.61-0.75. Further research is warranted to elucidate possible behaviors or characteristics associated with education that could explain the differences in incidence and survival, such as compliance with cancer screening...
  14. ncbi Marital status and cancer risk in Italy
    Giorgia Randi
    Istituto di Ricerche Farmacologiche Mario Negri, 20157 Milan, Italy
    Prev Med 38:523-8. 2004
    ..Marital status has long been related to cancer incidence and mortality rates. However, only few analytical studies have been conducted on this issue considering known or potential confounding factors...
  15. ncbi Epidemiology and aetiology of gestational trophoblastic diseases
    Andrea Altieri
    Laboratory of Epidemiology at the Mario Negri Institute of Pharmacological Research, Milan, Italy
    Lancet Oncol 4:670-8. 2003
    ....